Clinical Trials Browser

Adenocarcinoma of Lung, Burkitt Lymphoma, Adenocarcinoma, Bronchiolo-Alveolar, Carcinoma, Non-Small-Cell Lung, Hodgkin Disease, Immunoblastic Lymphadenopathy, Lung Neoplasms, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Lymphoproliferative Disorders, Waldenstrom Macroglobulinemia, Mycosis Fungoides, Sezary Syndrome, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Cutaneous, Lymphoma, Large-Cell, Anaplastic, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Lymphoma, Extranodal NK-T-Cell, Intraocular Lymphoma

Clinical Trials

Vandetanib and Everolimus in Treating Patients With Advanced or Metastatic Cancer

A Phase I Trial of Vandetanib (AZD6474) and Selumetinib (AZD6244) for Solid Tumours Including Non Small Cell Lung Cancer (VanSel-1)

A Trial of ZD6474, Paclitaxel, Carboplatin, 5-Fluorouracil, and Radiation Therapy Followed by Surgery

ZD6474 to Treat Advanced Brain Cancer in Patients

Vandetanib

Phase I Chinese PK

Open Label, Phase I ZD6474 Head and Neck Cancer Study

Dose Escalation Study With Zactima and Chemotherapy in Metastatic Pancreas Carcinoma

Phase I Combination With Vinorelbine or Gemcitabine Plus Cisplatin in Locally Advanced or Metastatic NSCLC

Phase I FOLFOX Combination

ZD6474(Vandetanib) + Alimta Combo Study

Phase I Irinotecan, 5-Fluorouracil and Leucovorin Combination

Vandetanib and Sirolimus in Patients With Recurrent Glioblastoma

Clinical Trial Evaluating the Combination of Vandetanib and Dasatinib During and After Radiation Therapy (RT) in Children With Newly Diagnosed Diffuse Intrinsic Pontine Glioma (DIPG)

Study of GemOx and Vandetanib in Advanced Solid Malignancy

Gemcitabine/Capecitabine/ZD6474 in Advanced Solid Tumors

ZD6474 (Zactima) and Metronomic Chemotherapy in Advanced Breast Cancer

IRUSZACT0073

Ph I Dose Escalation Trial of Vandetanib in Combo w Etoposide for Malignant Gliomas

Ph I Zactima + Imatinib Mesylate & Hydroxyurea for Pts w Recurrent Malignant Glioma

Vandetanib and Radiation Therapy in Treating Young Patients With Newly Diagnosed Diffuse Brainstem Glioma

ZD6474, Cetuximab, and Irinotecan in Patients With Metastatic Colorectal Cancer

Vandetanib and Bevacizumab in Treating Patients With Advanced Solid Tumors or Lymphoma